Awwad A. Radwan

1.0k total citations
55 papers, 770 citations indexed

About

Awwad A. Radwan is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Awwad A. Radwan has authored 55 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 14 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Awwad A. Radwan's work include Synthesis and biological activity (20 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and Synthesis and Biological Evaluation (7 papers). Awwad A. Radwan is often cited by papers focused on Synthesis and biological activity (20 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers) and Synthesis and Biological Evaluation (7 papers). Awwad A. Radwan collaborates with scholars based in Saudi Arabia, Egypt and United States. Awwad A. Radwan's co-authors include Fars K. Alanazi, Fars K. Alanazi, Ibrahim A. Alsarra, Gamal M. Mahrous, Mostafa M. Ghorab, Nazrul Haq, Faiyaz Shakeel, Abdullah Al‐Dhfyan, Wael M. Abdel‐Mageed and Tarek Aboul‐Fadl and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Awwad A. Radwan

54 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Awwad A. Radwan Saudi Arabia 15 313 212 114 105 101 55 770
Syed Hassan Mehdi India 15 197 0.6× 246 1.2× 134 1.2× 140 1.3× 88 0.9× 30 812
Marwa Sharaky Egypt 15 272 0.9× 262 1.2× 132 1.2× 64 0.6× 91 0.9× 78 892
Barbara Mavroidi Greece 17 218 0.7× 157 0.7× 117 1.0× 91 0.9× 110 1.1× 39 723
Hamad Alrbyawi Saudi Arabia 15 149 0.5× 168 0.8× 113 1.0× 79 0.8× 73 0.7× 33 556
Xiu-Rong Hu China 18 160 0.5× 177 0.8× 252 2.2× 166 1.6× 153 1.5× 81 859
Ayaz Mahmood Dar India 14 347 1.1× 206 1.0× 350 3.1× 119 1.1× 222 2.2× 39 1.1k
Meshal Alshamrani Saudi Arabia 16 123 0.4× 134 0.6× 125 1.1× 93 0.9× 102 1.0× 46 680
Uttam A. More India 18 403 1.3× 263 1.2× 51 0.4× 130 1.2× 64 0.6× 36 834
Alaa M. Alqahtani Saudi Arabia 14 279 0.9× 191 0.9× 127 1.1× 50 0.5× 58 0.6× 54 719
Damini Sood India 17 232 0.7× 411 1.9× 228 2.0× 85 0.8× 138 1.4× 23 912

Countries citing papers authored by Awwad A. Radwan

Since Specialization
Citations

This map shows the geographic impact of Awwad A. Radwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Awwad A. Radwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Awwad A. Radwan more than expected).

Fields of papers citing papers by Awwad A. Radwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Awwad A. Radwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Awwad A. Radwan. The network helps show where Awwad A. Radwan may publish in the future.

Co-authorship network of co-authors of Awwad A. Radwan

This figure shows the co-authorship network connecting the top 25 collaborators of Awwad A. Radwan. A scholar is included among the top collaborators of Awwad A. Radwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Awwad A. Radwan. Awwad A. Radwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Radwan, Awwad A., Gamal M. Mahrous, Adel F. Alghaith, et al.. (2025). Formulation of topical gel contains a novel benzoic acid derivative for skin infection treatment: in vitro and in vivo evaluations. Drug Development and Industrial Pharmacy. 51(3). 262–272. 1 indexed citations
4.
Radwan, Awwad A., Fars K. Alanazi, & Mohammad Raish. (2023). Design and synthesis of multi-functional small-molecule based inhibitors of amyloid-β aggregation: Molecular modeling and in vitro evaluation. PLoS ONE. 18(5). e0286195–e0286195. 5 indexed citations
5.
Radwan, Awwad A., et al.. (2023). Design, synthesis and molecular modeling of isatin-aminobenzoic acid hybrids as antibacterial and antibiofilm agents. Saudi Pharmaceutical Journal. 31(11). 101781–101781. 4 indexed citations
6.
Alanazi, Fars K., et al.. (2022). Molecular scaffold and biological activities of anti- Alzheimer agents. Tropical Journal of Pharmaceutical Research. 21(2). 439–451. 2 indexed citations
8.
Darwısh, Ibrahim A., Abdulrahman A. Almehizia, Awwad A. Radwan, & Rashed N. Herqash. (2020). Preparation and Characterization of Two Immunogens and Production of Polyclonal Antibody with High Affinity and Specificity for Darunavir. Molecules. 25(18). 4075–4075. 4 indexed citations
10.
Radwan, Awwad A., Falah Almohanna, Fars K. Alanazi, Pulicat Manogaran, & Abdullah Al‐Dhfyan. (2016). Target β-catenin/CD44/Nanog axis in colon cancer cells by certain N′-(2-oxoindolin-3-ylidene)-2-(benzyloxy)benzohydrazides. Bioorganic & Medicinal Chemistry Letters. 26(7). 1664–1670. 8 indexed citations
11.
Alanazi, Fars K., Nazrul Haq, Awwad A. Radwan, Ibrahim A. Alsarra, & Faiyaz Shakeel. (2015). Development and validation of UHPLC-DAD method for the determination of cholesteryl-hexahydrophthaloyl-5-fluorouracil in lipid nanoemulsion. Journal of Analytical Chemistry. 70(5). 593–599. 4 indexed citations
12.
Radwan, Awwad A., Mostafa M. Ghorab, Mansour S. Alsaid, & Fars K. Alanazi. (2014). Novel Ethyl 1,5-Disubstituted-1H-Pyrazole-3-Carboxylates as a New Class of Antimicrobial Agents. Acta Pharmaceutica. 64(3). 335–344. 8 indexed citations
13.
Alanazi, Fars K., Nazrul Haq, Awwad A. Radwan, Ibrahim A. Alsarra, & Faiyaz Shakeel. (2014). Cholesterol-Rich Nanoemulsions (LDE) for Drug Targeting of Cholesteryl-Succinyl- 5-Fluorouracil Conjugate. Current Nanoscience. 10(2). 287–291. 6 indexed citations
14.
Attia, Mohamed I., et al.. (2013). 1-Aryl-3-(1H-imidazol-1-yl)propan-1-ol esters: synthesis, anti-Candidapotential and molecular modeling studies. Chemistry Central Journal. 7(1). 168–168. 11 indexed citations
15.
Alanazi, Fars K., Nazrul Haq, Awwad A. Radwan, Ibrahim A. Alsarra, & Faiyaz Shakeel. (2013). Formulation and evaluation of cholesterol-rich nanoemulsion (LDE) for drug delivery potential of cholesteryl-maleoyl-5-fluorouracil. Pharmaceutical Development and Technology. 20(3). 266–270. 13 indexed citations
16.
Radwan, Awwad A. & Fars K. Alanazi. (2013). Targeting cancer using cholesterol conjugates. Saudi Pharmaceutical Journal. 22(1). 3–16. 67 indexed citations
17.
Ghorab, Mostafa M., et al.. (2013). Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus. Archives of Pharmacal Research. 36(6). 660–670. 22 indexed citations
18.
Radwan, Awwad A. & Kamal E. H. ElTahir. (2013). Synthesis and in-silico studies of some diaryltriazole derivatives as potential cyclooxygenase inhibitors. Archives of Pharmacal Research. 36(5). 553–563. 4 indexed citations
19.
Radwan, Awwad A., Abdullah Al‐Dhfyan, Mohammed K. Abdel‐Hamid, Abdullah A. Al‐Badr, & Tarek Aboul‐Fadl. (2012). 3,5-Disubstituted thiadiazine-2-thiones: New cell-cycle inhibitors. Archives of Pharmacal Research. 35(1). 35–49. 12 indexed citations
20.
Hayallah, Alaa M. & Awwad A. Radwan. (2007). SYNTHESIS AND QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP (QSAR) STUDY OF NEW 3- ALLYL-5-SUBSTITUTED-3,4,5,6-TETRAHYDRO-2H-1,3,5- THIADIAZINE-2-THIONES OF A POTENTIAL ANTIMICROBIAL ACTIVITY. Bulletin of Pharmaceutical Sciences Assiut. 30(1). 39–50. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026